Internationally Recognized Pioneer in Development of Stents for Blocked Arteries
Gary S. Roubin, MD, PhD, an internationally renowned interventional cardiologist recognized for his pioneering work in the development of stents-meshlike scaffolding used to treat blocked arteries-is being named Chairman of the newly created Department of Interventional Cardiology at Lenox Hill Hospital.
Dr. Roubin is an accomplished clinician, educator, and researcher who has conducted groundbreaking work in angioplasty and coronary stenting and is a leading authority in the endovascular treatment of peripheral artery and carotid artery disease. A prot?g? of the late Andreas Gruentzig, MD, the originator of balloon angioplasty, he was the co-inventor of the Gianturco-Roubin Flex-Stent, the first FDA-approved coronary artery stent.
Dr. Roubin was born in Australia and earned his medical degree at the University of Queensland in 1975. After completing his residency in internal medicine and cardiology at the Royal Prince Alfred Hospital and fellowship at the Hallstrom Institute of Cardiology in Sydney, he enrolled as a doctoral candidate in cardiovascular physiology at Sydney University and was awarded a PhD in 1983.
Dr. Roubin came to the United States in 1984 to undertake post-doctoral research with Dr. Gruentzig at Emory University. In 1989, Dr. Roubin was named professor of medicine and radiology, and director of the cardiac catheterization laboratories and interventional cardiology at the University of Alabama Hospital. In 1995, he was awarded a post doctorate in medicine from the University of Queensland for his basic and clinical research in the development of coronary stenting.
From 1997 to 2003, Dr. Roubin was director of endovascular therapy at Lenox Hill Hospital. Over the past year, he has focused his research on the NIH-funded Carotid Revascularization vs. Stenting Trial (CREST), comparing the outcomes of carotid artery stenting and carotid endarterectomy surgery, for which he is co-principal investigator. He also conducted major educational programs and maintained a clinical practice at the LDS Hospital in Salt Lake City. He is a clinical professor of medicine at New York University School of Medicine.
"Dr. Roubin brings to Lenox Hill Hospital incomparable experience and expertise as a clinician, inventor, researcher and educator in the field of interventional cardiology," said Gladys George, President and CEO of Lenox Hill Hospital. "His return to Lenox Hill Hospital as Chairman of this newly created department will enable us to elevate an already outstanding program to an even higher level of national stature."
Recruitment of National Leaders in Cardiology
Under Dr. Roubin's leadership and expertise, the Department will expand in both depth and breadth of service. "The renowned cardiologists we are recruiting from among the most highly respected institutions throughout the country combined with the eminent physicians and surgeons at Lenox Hill Hospital will take the Lenox Hill Heart & Vascular Institute to new heights," said Dr. Roubin. "New and expanded initiatives will include left atrial appendage closure; closure of patent foramen ovale, a cause of stroke in people under 60 years of age; and percutaneous mitral valve repair."
Dr. Roubin's interests have included the development of device technology, innovative techniques for the treatment of coronary and peripheral atherosclerosis and research in the application of coronary angioplasty in patients with multi-vessel coronary disease. He was co-principal investigator in the NHLBI-sponsored EAST study comparing PTCA and bypass surgery in multi-vessel coronary disease, and was the leading U.S. interventional cardiologist in the NHLBI-sponsored BARI trial, comparing percutaneous and bypass surgery in patients with complex coronary disease.
He is a fellow of the American College of Cardiology, the Council on Clinical Cardiology of the American Heart Association, the Society for Cardiac Angiography and Intervention, the Society for Vascular Medicine and Biology, the International Society of Endovascular Specialists, Society of Interventional Radiology and the newly formed International Society for Vascular Surgery.
Dr. Roubin has published more than 160 papers and 200 abstracts in peer review journals. He has edited two textbooks on interventional cardiovascular medicine and coronary artery stenting and contributed to 15 textbooks on interventional cardiology. He lectures extensively in the United States and abroad and has received numerous awards for his notable contributions to cardiac care. The pioneering work he does in the catheterization laboratory has been seen live by physicians and healthcare professionals via satellite around the world over the past two decades.
Dr. Roubin, his wife Peta and four children maintain homes in Manhattan and Jackson, Wyoming.
Lenox Hill Hospital has performed pioneering work in the field of cardiovascular disease for more than 50 years, and has been named one of the top 50 hospitals for cardiology and heart surgery nationwide in U.S. News & World Report's annual surveys. Lenox Hill Heart and Vascular Institute physicians and surgeons are in the forefront of research in the fields of cardiac, carotid and peripheral vascular disease. The first angioplasty in the United States was performed at Lenox Hill Hospital more than 25 years ago, and last year Lenox Hill Hospital physicians performed the first drug-eluting stent procedure after FDA approval in the United States.
Members of the press seeking information about Lenox Hill Hospital should call the Public Relations Department at (212) 434-2400.